IL-17 Archives - Medical Conferences

Targeting IL-17A offers a promising treatment perspective in hidradenitis suppurativa

Presented By

Dr Kim Papp, Probity Medical Research, Canada

Trial

Phase 3

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:26

Bimekizumab shows sustained 2-year efficacy in hidradenitis suppurativa

Presented By

Prof. Christos Zouboulis, Dessau Medical Center, Germany

Trial

BE HEARD

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:22

PsoBest registry: Biologics dominate treatment for moderate-to-severe psoriasis

Presented By

Prof. Matthias Augustin, University Medical Center Hamburg-Eppendorf, Germany

Trial

PsoBest registry

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 12:23

Dual IL-17A/F blocker significantly reduces spinal radiographic progression in radiographic axSpA

Presented By

Prof. Xenofon Baraliakos, Ruhr-University Bochum, Germany

Trial

Phase 3, BE MOBILE 2

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:38

Small protein targeting IL-17A effective in PsA management

Presented By

Prof. Philip Mease, University of Washington; Swedish Medical Center, WA, USA

Trial

Phase 2

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:37

How close are we to personalised medicine in psoriatic arthritis?

Presented By

Prof. Ennio Lubrano, University of Molise, Ital

Conference

IFPA 2024

Type

News article

17 July 2024 14:38

Depression complicates the management of psoriatic disease

Presented By

Dr Wiebke Sondermann, University Hospital Essen, Germany

Conference

IFPA 2024

Type

News article

17 July 2024 14:20

The unfavourable role of obesity in psoriatic disease

Presented By

Prof. Ulrich Mrowietz, University Medical Center Schleswig-Holstein, Germany

Conference

IFPA 2024

Type

News article

17 July 2024 14:13

Multiple novel oral agents show promise in psoriasis

Presented By

Prof. April Armstrong, University of California Los Angeles, USA

Trial

FRONTIER; STRIDE

Conference

IFPA 2024

17 July 2024 14:04

Biologics in psoriatic arthritis: where we are and where we are headed

Presented By

Dr Vinod Chandran

Conference

IFPA 2024

Type

News article

17 July 2024 11:55

IL-23 blockers may lower the risk of developing inflammatory and psoriatic arthritis

Presented By

Prof. Bruce Strober, Yale University School of Medicine, USA

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 12:01

Anti-IL17 blockade leads to maintained pain reduction in patients with HS

Presented By

Dr John Ingram, Cardiff University, UK

Trial

Phase 3, SUNSHINE; SUNRISE

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 11:44

Switching to risankizumab successful in IL-17 inhibitor non-responders

Presented By

Prof. Richard Warren, University of Manchester, UK

Trial

Phase 3, aIMM study

Conference

AAD 2023

Type

Peer-reviewed article

15 May 2023 11:56

Bimekizumab: Robust 1-year results in treating psoriatic arthritis

Presented By

Prof. Christopher Ritchlin, University of Rochester Medical Center, USA

Trial

Phase 3

Conference

ACR 2022

Type

News article

1 December 2022 14:33

New treatments for HS: IL-17 inhibitors next in practice?

Presented By

Dr Axel Villani, University of Lyon, France & Prof. Thrasyvoulos Tzellos, Nordland Hospital Trust, Norway

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:05

Psoriatic arthritis: significant improvement with bimekizumab

Presented By

Prof. Iain McInnes , Glasgow University, United Kingdom

Trial

Phase 3, BE OPTIMAL

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 14:36

Potential biomarker discovered for treatment response to ustekinumab

Presented By

Mr Shane Solanky, King’s College London, UK

Conference

PFGC 2021

Type

Peer-reviewed article

3 February 2022 15:46

Explaining arthropathy development through IL-4 and IL-13 blockade

Presented By

Dr Charlie Bridgewood, University of Leeds, UK

Conference

PFGC 2021

Type

Peer-reviewed article

3 February 2022 10:51

Patients on immunomodulators need 2 COVID-19 vaccinations before seroconversion

Presented By

Dr Ali Al-Janabi, University of Manchester, UK

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 15:22

IL-17 inhibition showing efficacy in GCA in phase 2 trials

Presented By

Prof. Jens Thiel, Medical University Graz, Austria

Trial

Phase 2, TitAIN

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 11:05

Why antipsychotics cause weight gain

Presented By

Prof. Louise Gallagher, University of Dublin, Ireland

Conference

ECNP 2021

Type

Peer-reviewed article

26 November 2021 11:18

Existing and upcoming small molecules in psoriasis

Presented By

Dr Enikö Sonkoly , Karolinska University Hospital, Sweden

Trial

POETYK PSO; PSOARING

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:19

Active PsA: Biomarkers distinguish radiographic progressors from non-progressors

Trial

Phase 3, SPIRIT-P1

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:37

Psoriatic arthritis: Guidelines and best practice

Trial

Phase 3, BE ACTIVE, PATERA

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 11:19

Psoriasis: New treatments and current pipeline

Presented By

Prof. Kristian Reich, Dermatologikum Hamburg, Germany

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 11:08

Efficacy and safety of secukinumab in juvenile idiopathic arthritis

Presented By

Dr Nicola Ruperto, IRCCS Istituto G. Gaslini, Italy

Trial

Phase 3, JUNIPERA

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 23:33

Psoriasis and hidradenitis suppurativa during COVID-19: keep calm and carry on

Presented By

Prof. April W. Armstrong, University of Southern California, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:32

Psoriasis: The treatment armamentarium continues to grow

Presented By

Prof. Bruce Strober, Yale University, CT, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:32

IL-17 inhibitor effective in axial manifestations of psoriatic arthritis

Trial

Phase 3, MAXIMISE

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:00

Promising results with nanobody treatment in psoriasis

Presented By

Dr Kim A. Papp, Probity Medical Research, Canada

Trial

Phase 2

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 13:40

Efficacious non-steroidal topical for psoriasis

Presented By

Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, USA

Trial

Phase 3, PSOARING

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 13:28

AxSpA real-life remission rates higher on biologics

Presented By

Dr Charlotte Baert, Saint Luc University Hospital, Belgium

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 10:24

IL-17A and IL-17F blockade remarkably effective in psoriasis

Presented By

Prof. Kristian Reich; Prof. Kenneth B. Gordon

Trial

BE VIVID and BE READY

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 07:09

Novel IL-23 blocker risankizumab highly effective and tolerable in psoriasis

Presented By

Prof. Richard B. Warren

Trial

IMMerge

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 07:07

IL-17A blocker effective in paediatric psoriasis patients

Presented By

Dr Kim Papp, Probity Medical Research, Canada

Trial

Phase 3, IXORA-PEDS

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 20:51

No hint of teratogenicity through ixekizumab

Presented By

Prof. Alexander Egeberg, Herlev and Gentofte Hospital, Denmark

Trial

PSOLAR

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 14:32

Efficacy and safety of bimekizumab in patients with active PsA

Presented By

Dr Christopher Ritchlin, University of Rochester Medical Centre, USA

Trial

Phase 2, BE ACTIVE

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 11:10

Biologicals beyond TNF blockade

Presented By

Prof. Brian Kirby, St. Vincent’s University Hospital, Ireland

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 11:11

Registries – an important research tool in biologics

Presented By

Prof. Bruce E. Strober, UConn Health, USA

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 10:10

Advances in target-oriented therapy: psoriatic arthritis

Presented By

Prof. Wolf-Henning Boehncke, University of Geneva, Switzerland

Trial

ECLIPSA, TICOPA

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 23:48

Understanding genetics to unravel psoriasis and atopic dermatitis pathogenesis

Presented By

Prof. Jonathan Barker, Kings College London, United Kingdom

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 20:34

Results from the ECLIPSE trial: does blocking IL-23 have better long-term outcomes in psoriasis?

Presented By

Prof. Kristian Reich, Georg-August-University Göttingen, Germany

Trial

ECLIPSE

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 18:23

Atopic dermatitis and psoriasis: on a spectrum?

Presented By

Prof. Emma Guttman-Yassky, Mount Sinai Medical School, USA

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 13:39

IBD risk of treatment with IL-17 antagonists

Presented By

Dr Wolfgang Eigner, Medical University of Vienna, Austria

Conference

ECCO 2019

Type

Peer-reviewed article

9 May 2019 14:37

Secukinumab maintains improvements in psoriasis through 5 years of treatment

Presented By

Prof. Richard Langley, Dalhousie University, Canada

Trial

ERASURE/FIXTURE

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 23:10

Dual IL-17A and IL-17F blocker leads to unprecedented response rates in psoriasis

Presented By

Dr Andrew Blauvelt, Oregon Medical Research Center, USA

Trial

BE ABLE

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 19:24

Psoriasis and Biologics: The Beat Goes On

Presented By

Prof. Mark Lebwohl, Mount Sinai School of Medicine, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 14:06